Attached files
| file | filename |
|---|---|
| S-1/A - QUARK PHARMACEUTICALS INC | v205860_s1a.htm |
| EX-10.35 - QUARK PHARMACEUTICALS INC | v205860_ex10-35.htm |
| EX-10.34 - QUARK PHARMACEUTICALS INC | v205860_ex10-34.htm |
| EX-10.31 - QUARK PHARMACEUTICALS INC | v205860_ex10-31.htm |
Exhibit 23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the reference to our firm under the caption “Experts” and to the use
of our report dated September 24, 2010, (except Notes 1 and 15, as to which the
date is December 17, 2010) in the Registration Statement (Form S-1 No.
333-169584) and the related Prospectus of Quark Pharmaceuticals, Inc. dated
December 17, 2010.
|
December
17, 2010
|
/s/
Kost Forer Gabbay & Kasierer
|
|
Tel-Aviv,
Israel
|
Kost
Forer Gabbay & Kasierer
|
|
|
A
Member of Ernst & Young Global
|